![](/img/cover-not-exists.png)
860 PHASE III RANDOMIZED TRIAL OF SUNITINIB MALATE VERSUS INTERFERON-ALFA AS FIRST-LINE SYSTEMIC THERAPY FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
O. Rixe, T.E. Hutson, P. Tomczak, M.D. Michaelson, R.M. Bukowski, S. Oudard, S. Negrier, S.T. Kim, I. Chen, R.A. Figlin, R.J. MotzerVolume:
6
Year:
2007
Language:
english
DOI:
10.1016/s1569-9056(07)60855-0
File:
PDF, 328 KB
english, 2007